Om

Hisamitsu Pharmaceutical Co., Inc. is a distinguished player in the pharmaceutical industry, primarily engaged in the development, production, and distribution of therapies centered around transdermal drug delivery systems. These systems play a critical role in healthcare by allowing for the controlled release of medication through the skin, offering significant benefits in terms of patient comfort and compliance. Notable products include their flagship branded patches such as Salonpas, which is widely used for pain relief globally. Hisamitsu's innovations are particularly impactful in the pain management sector but also extend into other therapeutic areas, enhancing the delivery methods for various treatments. With a rich legacy dating back to its founding in 1847 and headquartered in Saga, Japan, the company holds a significant market presence across Asia, North America, and Europe. Hisamitsu's commitment to research and development underpins its strategic initiatives to expand its reach and influence in the global pharmaceutical landscape, focusing on solutions that improve quality of life.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I HISAMITSU PHARMACEUTICAL CO MED ENDAVU: Køb Hisamitsu Pharmaceutical Co ($HPX) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Hisamitsu Pharmaceutical Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.